Targeting critical
unmet needs
With our innovative SmartKine® technology, we’re developing novel prodrugs to address critical unmet medical needs in oncology and autoimmune disease treatment.
Elevating the therapeutic
potential of cytokines.
By avoiding “cytokine sink” and peripheral toxicity, our SmartKine® platform significantly extends the pharmacokinetics of cytokines, powering next-generation prodrugs with improved safety profiles.
Explore Our Science
Targeting critical
Led by world-class scientists
We are led by a team of pioneering scientists focused on a shared goal: to make AskGene Pharma the global leader in cytokine prodrugs, providing safer and better medicines for saving patients’ lives.
AskGene News:
